Obeda 4mg Pre-filled Pen (with BD Ultra-Fine 32G – 4 Needle)

Obeda 4 mg Pre-filled Pen – Semaglutide for Type 2 Diabetes Management

Obeda 4 mg Pre-filled Pen is a prescription injectable medicine containing Semaglutide 4 mg in 3 ml. The pre-filled pen provides four fixed doses of 1 mg for once-weekly subcutaneous administration. Semaglutide belongs to a class of medicines called glucagon-like peptide-1 receptor agonists, also known as GLP-1 receptor agonists. It helps improve blood-sugar control by supporting insulin release when glucose levels are elevated, reducing excess glucagon secretion, and slowing gastric emptying. The combipack includes one pre-filled disposable pen and four BD Ultra-Fine 32G disposable needles.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 4 mg Pen Strength: Contains a total of 4 mg semaglutide in 3 ml.
• 1 mg Per Dose: Delivers four fixed doses of 1 mg each.
• Once-Weekly Administration: Designed for use on the same day every week.
• Pre-filled Disposable Pen: Provides convenient subcutaneous administration.
• Needles Included: Supplied with four BD Ultra-Fine 32G disposable needles.
• Prescription Medicine: Intended for use according to a healthcare professional’s treatment plan.

Active Ingredient

• Semaglutide 4 mg in 3 mL: Each fixed weekly dose delivers 1 mg of semaglutide.

Uses

• Management of insufficiently controlled type 2 diabetes mellitus in adults.
• Improvement of blood-glucose control alongside diet and regular physical activity.
• May be used alone when metformin is unsuitable.
• May be prescribed with other diabetes medicines when additional glucose control is required.
• Supports reduction of HbA1c as part of a medically supervised diabetes-management programme.

How to Use

• Use Obeda exactly as prescribed by your healthcare professional.
• Inject one prescribed 1 mg dose once weekly on the same day each week.
• The injection may be administered at any time of the day, with or without meals.
• Inject it under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection area with every weekly dose.
• Attach a new BD Ultra-Fine 32G needle before every injection.
• Check that the solution is clear and colourless before administration.
• Follow the flow-check and dose-selection instructions supplied with the pen.
• Select only the prescribed fixed dose.
• Remove and safely discard the needle immediately after each injection.
• Never share the pen or needles with another person.
• Discard the pen after all four prescribed doses have been used.

Precautions

• The 1 mg dose is generally used after treatment with lower semaglutide strengths.
• It is not intended for type 1 diabetes or diabetic ketoacidosis.
• Inform your doctor if you have pancreatitis, severe digestive problems, kidney disease, gallbladder problems, or diabetic retinopathy.
• Nausea, vomiting, or diarrhoea may cause dehydration.
• The risk of low blood sugar may increase when used with insulin or sulfonylurea medicines.
• Report severe persistent abdominal pain or significant vision changes promptly.
• Do not combine it with another semaglutide product or GLP-1 receptor agonist unless prescribed.
• Do not change the dose or stop another diabetes medicine without medical advice.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion or acid reflux.
• Bloating or increased gas.
• Reduced appetite.
• Dizziness or fatigue.
• Injection-site redness, itching, or irritation.
• Low blood sugar when combined with certain diabetes medicines.

Storage

• Before first use, store in a refrigerator between 2°C and 8°C.
• Do not freeze or use a pen that has been frozen.
• Keep the pen away from the refrigerator’s cooling element.
• Keep the pen cap attached to protect the solution from light.
• After first use, store below 30°C or in a refrigerator between 2°C and 8°C.
• Do not store the pen with a needle attached.
• Do not use if the solution appears cloudy, coloured, or contains visible particles.
• Keep out of reach of children.

Legal Disclaimer: Obeda 4 mg Pre-filled Pen is a prescription semaglutide medicine intended for adults with type 2 diabetes. The dose, treatment duration, and combination with other diabetes medicines must be determined by a qualified healthcare professional. This information is provided for educational purposes and should not replace the instructions supplied with the product.